Pancreatic ductal adenocarcinoma (PDAC) carries significant morbidity and mortality and remains one of the most difficult malignancies to treat. Individual patient and tumor factors need to be taken into account to provide an optimal, personalized approach. In this review, we highlight established and novel biomarkers that have the potential to be used as prognostic biomarkers in pancreatic ductal adenocarcinoma and some that may be used to guide treatment decisions.

Pancreatic cancer is the 10th most common new cancer and the fourth leading cause of cancer death in men and women. This quick quiz will test your knowledge of pancreatic cancer risk factors, diagnosis, and how pancreatic cancer.

Pancreatic cancer is a type of cancer that forms in certain cells of the pancreas. Most patients with pancreatic cancer (about 95%) start in the exocrine pancreas. Tumors can also form in the endocrine pancreas, but these are uncommon and are usually benign (not cancerous).

Pancreatic carcinoma (PDAC) is one of the most difficult malignancies to treat. Individual patient and tumor factors need to be taken into account to provide an optimal, individualized approach. In this article, biomarkers for pancreatic cancer prognosis and some can be used to guide treatment decisions.

Pancreatic cancer is cancer that forms in certain cells of the pancreas. Most patients with pancreatic cancer (about 95%) start in the exocrine pancreas. Tumors can also form in the endocrine pancreas, but these are uncommon and are usually benign (not cancerous).

Pancreatic cancer or pancreatic adenocarcinoma (PDAC) is a deadly disease with a 5-year survival rate of about 6%. Accordingly, the oral or fecal microbiota could be a novel and potential diagnostic biomarker for pancreatic cancer.

Irinotecan Liposome is effective in the treatment of pancreatic carcinoma with metastasis. This is a prescription drug so make sure you consult your doctor before using it.

Topping the list of cancers with the highest mortality rate in Vietnam is pancreatic cancer. Therefore, it is not exaggerated to call pancreatic cancer a silent killer. So what is pancreatic cancer? Is pancreatic cancer curable? The following article will give you information about cancer known as the silent killer?